Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

(2019) Nicholas J. Thomas et al.   DIABETOLOGIA

Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of

(2019) H. Yaghootkar et al.   DIABETIC MEDICINE

Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension

(2018) Yingjie Ji et al.   DIABETES

A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy

(2018) Anita L. Grubb et al.   DIABETES CARE

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease

(2016) Hanieh Yaghootkar et al.   DIABETES

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Are cholesterol levels being checked and managed appropriately in UK primary care type 2 diabetes?

(2015) M. Livingston et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Genetic Evidence for a Normal-Weight "Metabolically Obese" Phenotype Linking Insulin Resistance, Hypertension, Coronary Artery Disease, and Type 2 Diabetes

(2014) H. Yaghootkar et al.   DIABETES

Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes

(2014) Valgerdur Steinthorsdottir et al.   NATURE GENETICS

Discovery and refinement of loci associated with lipid levels

(2013) Cristen J Willer et al.   NATURE GENETICS

What makes UK Biobank special?

(2012) Rory Collins   LANCET

Fatty Kidney, Hypertension, and Chronic Kidney Disease

(2011) Meredith C. Foster et al.   HYPERTENSION

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study

(2010) Elizabeth K. Speliotes et al.   HEPATOLOGY

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)

(2009) Jingzhong Ding et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

(2009) E. Fabbrini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease

(2008) Jeffrey B. Schwimmer et al.   CIRCULATION

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

(2008) R. Taylor   DIABETOLOGIA